Inicio › Cáncer de próstata › Míchigan
Ensayos clínicos de Cáncer de próstata en Míchigan
58 estudios sobre Cáncer de próstata buscan participantes en Míchigan.
Ciudades en Míchigan
- Ann Arbor26 estudios
- Detroit23 estudios
- Grand Rapids21 estudios
- Lansing10 estudios
- Canton8 estudios
- Clinton Township8 estudios
- Farmington Hills8 estudios
- Livonia7 estudios
- Flint7 estudios
- Waterford7 estudios
- Warren7 estudios
- Dearborn6 estudios
- Jackson5 estudios
- Saginaw5 estudios
- Troy5 estudios
- Wyoming4 estudios
- Kalamazoo3 estudios
Texto oficial del estudio (inglés)
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health Medical Center - Brighton, Brighton
- y 32 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03866382Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Wayne State University, Detroit
Reclutando
Edades de 18 en adelante · Hombres · Actualizado el 12 nov 2026 · NCT06511141A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.
- Henry Ford Health, Detroit
Reclutando
Todas las edades · Hombres · Actualizado el 12 nov 2026 · NCT07348367Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- START Midwest, Grand Rapids
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT04557449Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
- University of Michigan Rogel Cancer Center, Ann Arbor
ReclutandoEstudio observacional
Edades de 40 a 80 · Hombres · Actualizado el 9 nov 2026 · NCT05965180First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- GSK Investigational Site, Grand Rapids
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 9 nov 2026 · NCT07332455The Vanguard Study: Testing a New Way to Screen for Cancer
- Henry Ford Cancer Institute-Downriver, Brownstown
- Henry Ford Health Center - Brownstown, Brownstown
- Henry Ford Health Center - Chesterfield, Chesterfield
- y 13 más
ReclutandoSe aceptan voluntarios sanos
Edades de 45 a 75 · Todos los sexos · Actualizado el 6 nov 2026 · NCT06995898Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Henry Ford, Novi
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 5 nov 2026 · NCT07745361A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06465069Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MyMichigan Medical Center Gratiot, Alma
- MyMichigan Medical Center Alpena, Alpena
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- y 71 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Barbara Ann Karmanos Cancer Institute, Detroit
- BAMF Health Inc., Grand Rapids
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07114601Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
- y 3 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06632977A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- Cancer And Hematology Centers Of Western Michigan, Holland
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT07723248A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
- Start Midwest, Grand Rapids
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT07746713Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Bronson Battle Creek, Battle Creek
- Henry Ford Cancer Institute-Downriver, Brownstown
- y 17 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT07200830Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
- y 8 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT06931340Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- South Texas Accelerated Research Therapeutics, LLC (START), Grand Rapids
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT06800313A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- BAMF Health, Grand Rapids
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 2 nov 2026 · NCT07581184A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- University of Michigan ( Site 0005), Ann Arbor
- Henry Ford Hospital ( Site 0035), Detroit
- Cancer and Hematology Centers of Western Michigan ( Site 0015), Grand Rapids
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 30 oct 2026 · NCT06925737Precision-Based Genomics in Prostate Cancer
- University of Michigan, Ann Arbor
ReclutandoEstudio observacional
Edades de 18 a 120 · Hombres · Actualizado el 26 oct 2026 · NCT04706663Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Trinity Health Medical Center - Brighton, Brighton
- y 26 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 23 oct 2026 · NCT05946213Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Research Site, Ann Arbor
- Research Site, Detroit
ReclutandoFase 1/2
Edades de 18 a 130 · Hombres · Actualizado el 22 oct 2026 · NCT07181161A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 129, Detroit
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 oct 2026 · NCT05914116A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Henry Ford Hospital ( Site 0015), Detroit
- Cancer and Hematology Centers of Western Michigan ( Site 0005), Grand Rapids
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 oct 2026 · NCT06136650A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Barbara Ann Karmanos Cancer Institute, Lansing
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 20 oct 2026 · NCT07213674AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Grand Rapids
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 19 oct 2026 · NCT07611110Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Research Site, Detroit
- Research Site, Grand Rapids
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 15 oct 2026 · NCT07711002Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Karmanos Cancer Institute, Detroit
ReclutandoFase 3
Edades de 18 a 100 · Hombres · Actualizado el 15 oct 2026 · NCT06855277Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial
- University of Michigan Rogel Cancer Center, Ann Arbor
ReclutandoSe aceptan voluntarios sanos
Edades de 50 a 75 · Hombres · Actualizado el 15 oct 2026 · NCT07526545This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Michigan Institute of Urology, PC, Troy
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 14 oct 2026 · NCT07028853Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Saint Joseph Mercy Hospital, Ann Arbor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Saint Joseph Mercy Brighton, Brighton
- y 18 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 8 oct 2026 · NCT03678025A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- START Midwest, Grand Rapids
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 24 sept 2026 · NCT07719361Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])
- BAMF Health, Grand Rapids
ReclutandoFase 2/3
Edades de 18 en adelante · Hombres · Actualizado el 21 sept 2026 · NCT07831824Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 17 sept 2026 · NCT04038502Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- BAMF Health, Grand Rapids
- Corewell Health, Grand Rapids
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 11 sept 2026 · NCT06056830Prostate Active Surveillance Study
- University of Michigan, Ann Arbor
ReclutandoEstudio observacional
Edades de 21 en adelante · Hombres · Actualizado el 2 sept 2026 · NCT00756665A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
- Research Site, Grand Rapids
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 2 sept 2026 · NCT07192614COMPASS Study for Metastatic Castration-resistant Prostate Cancer
- Rogel Cancer Center, Ann Arbor
ReclutandoEstudio observacional
Edades de 18 en adelante · Hombres · Actualizado el 27 ago 2026 · NCT07050433A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Karmanos Cancer Institute, Detroit
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 20 ago 2026 · NCT06785636EDRN Prostate MRI Biomarker Study
- University of Michigan, Ann Arbor
ReclutandoEstudio observacional
Edades de 18 en adelante · Hombres · Actualizado el 17 ago 2026 · NCT03784924De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.